top of page






About
This scientific animation presents the Pinot-ADC platform, designed to create novel ADC therapeutics with safe, effective camptothecin drugs and optimized linkers. It focuses on PBX-1, an ADC candidate targeting the Trop2 antigen, demonstrating efficient drug delivery, resistance bypass, and potent anti-cancer effects. Through innovative features like pH-sensitive linkers and reduced receptor recycling, PBX-1 offers a promising new avenue for advanced cancer therapies.
Client
Biopharmaceutical company
Primary Audience
Potential Business Partners








